HomeLABFF • OTCMKTS
add
Laboratorios Farmaceuticos ROVI SA
Previous close
$90.61
Year range
$86.05 - $90.61
Market cap
3.93B EUR
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 178.16M | -0.59% |
Operating expense | 73.15M | 9.39% |
Net income | 29.38M | 53.15% |
Net profit margin | 16.49 | 53.97% |
Earnings per share | — | — |
EBITDA | 40.59M | 45.73% |
Effective tax rate | 20.88% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 45.12M | -70.99% |
Total assets | 857.32M | -4.72% |
Total liabilities | 374.56M | -1.44% |
Total equity | 482.76M | — |
Shares outstanding | 51.15M | — |
Price to book | 10.16 | — |
Return on assets | 11.36% | — |
Return on capital | 15.36% | — |
Cash Flow
Net change in cash
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 29.38M | 53.15% |
Cash from operations | 14.20M | -49.32% |
Cash from investing | -9.58M | 23.72% |
Cash from financing | 26.86M | 958.82% |
Net change in cash | 31.49M | 155.00% |
Free cash flow | 77.17M | -6.31% |
About
Founded
1946
Website
Employees
2,137